| 000 | 01842 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517093206.0 | ||
| 264 | 0 | _c20171218 | |
| 008 | 201712s 0 0 eng d | ||
| 022 | _a1872-8332 | ||
| 024 | 7 |
_a10.1016/j.lungcan.2016.03.008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOu, Sai-Hong Ignatius | |
| 245 | 0 | 0 |
_aAlectinib induced CNS radiation necrosis in an ALK+NSCLC patient with a remote (7 years) history of brain radiation. _h[electronic resource] |
| 260 |
_bLung cancer (Amsterdam, Netherlands) _c06 2016 |
||
| 300 |
_a15-8 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xmetabolism |
| 650 | 0 | 4 | _aAdenocarcinoma of Lung |
| 650 | 0 | 4 | _aAnaplastic Lymphoma Kinase |
| 650 | 0 | 4 |
_aBrain _xdrug effects |
| 650 | 0 | 4 |
_aBrain Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCarbazoles _xadverse effects |
| 650 | 0 | 4 | _aCrizotinib |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNecrosis _xchemically induced |
| 650 | 0 | 4 |
_aPiperidines _xadverse effects |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aPyrazoles _xpharmacology |
| 650 | 0 | 4 |
_aPyridines _xpharmacology |
| 650 | 0 | 4 |
_aRadiation Injuries _xchemically induced |
| 650 | 0 | 4 |
_aReceptor Protein-Tyrosine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aWeitz, Michael | |
| 700 | 1 | _aJalas, John R | |
| 700 | 1 | _aKelly, Daniel F | |
| 700 | 1 | _aWong, Vanessa | |
| 700 | 1 | _aAzada, Michele C | |
| 700 | 1 | _aQuines, Oliver | |
| 700 | 1 | _aKlempner, Samuel J | |
| 773 | 0 |
_tLung cancer (Amsterdam, Netherlands) _gvol. 96 _gp. 15-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.lungcan.2016.03.008 _zAvailable from publisher's website |
| 999 |
_c25976713 _d25976713 |
||